OTCMKTS:LCDX

Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
950 shs
Average Volume
1,439 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LCDX stock logo

About Caliber Imaging & Diagnostics Stock (OTCMKTS:LCDX)

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.

LCDX Stock News Headlines

Caliber Imaging & Diagnostics, Inc. (LCDX)
Caliber Imaging & Diagnostics Inc.
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Caliber Imaging & Diagnostic (LCDX) Gets a Hold from RBC Capital
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
Caliber Imaging & Diagnostics Inc (LCDX)
See More Headlines
Receive LCDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Caliber Imaging & Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
OTCMKTS:LCDX
CIK
N/A
Fax
N/A
Employees
28
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. William J. Shea (Age 76)
    Executive Chairman
  • Mr. L. Michael Hone (Age 74)
    CEO & Director
    Comp: $350k
  • Mr. William J. Fox (Age 58)
    CTO & VP of Technology Operations
    Comp: $139.16k
  • Ms. Karen Howe
    Chief Financial Officer
  • Mr. Robert T. Kelley
    Vice President of Sales & Marketing

LCDX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Caliber Imaging & Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Caliber Imaging & Diagnostics investors own include Etsy (ETSY), J C Penney (JCP), NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Youdao (DAO), Advanced Micro Devices (AMD), Costco Wholesale (COST), International Business Machines (IBM) and Netflix (NFLX).

How do I buy shares of Caliber Imaging & Diagnostics?

Shares of LCDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LCDX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners